Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure
NCT ID: NCT05871138
Last Updated: 2023-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2023-03-30
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Congestion and LActate at diScHarge in Acute Heart Failure
NCT07345156
Systolic Time Intervals a Prognostic Tool of Heart Failure in Emergency Departement (STI/AHF)
NCT03831204
1 Year Post Discharge Prognostic Model From the National Heart Failure Audit (NHFA)
NCT02353481
Short and Long Term Prognosis of Patients Admitted to the ED With Acute Heart Failure
NCT03806972
Prognostic Model Heart Failure
NCT06414928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Delta LUS score=((LUS2-LUS1) \*100)/LUS1
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit).
Exclusion Criteria
* Dyspnea of non-cardiac etiology (cause: pulmonary, traumatic, toxic...)
* Altered state of consciousness (Glasgow score\<14)
* Hemodynamic instability: presence of peripheral signs of shock, use of vasoactive drugs
* Mechanical ventilation from the outset
* Cardiorespiratory arrest
* Inability to give consent to the study
* Missing one of two ultrasound examinations
* Unable to make telephone contact after one month.
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Monastir
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pr. Semir Nouira
clinical proffesor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nouira Semir, Pr
Role: PRINCIPAL_INVESTIGATOR
University of Monastir
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Semir Nouira
Monastir, Monastur, Tunisia
Emergency Departement
Monastir, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Delta- LUS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.